Recession forces restructure.

The article reports on the impact of global economic crisis on the pharmaceutical industry in Great Britain. It indicates that pharmaceutical firms are under pressure in increasing their revenues due to the recession which forced them to be involved in mergers or restructuring to cut costs and manage their portfolios. It also mentions on the plan of Eli Lilly to establish a Development Center of Excellence which is designed to enhance the late-stage development of new medicines.